Nanomaterials Are Changing the World – But We Still Don’t Have Adequate Safety Tests for Them
TECHNOLOGY, 14 Jan 2019
Shareen Doak, Martina G. Vijver and Martin Clift – The Conversation
joker1991/Shutterstock
10 Jan 2019 – Nanotechnology may well be one of the most talked about industries of the last few years. Predicted to value US$173.95 billion globally by 2025, this fast-moving sector is already delivering major sustainability, health and well-being benefits to society.
Nanomaterials, as the name suggests, are very small, less than a millionth of a metre in size. They have unique physical and chemical features which give them improved properties such as greater reactivity, strength, electrical characteristics and functionality. These benefits have resulted in nanomaterials being incorporated into a wide range of consumer products. The automotive, computing, electronic, cosmetics, sports and healthcare industries all benefit from nanotechnology innovations. New fields have also emerged, such as nanomedicine, which aims to dramatically improve our future ability to treat disease.
But exciting as this may sound, as with any innovation, we must ensure that human health and environmental impacts are considered. And this is not a simple task. Although standard hazard assessments are available for a wide range of things – such as chemical compounds – nanomaterials have unique properties so cannot be evaluated in exactly the same way.
Environmental health and humans
Nanomaterials are already entering our environment, albeit at low levels. They are being found in waste water from products like toothpaste, sun lotion, and when items such as nano-silver socks (which prevent smelly feet) are washed. Short-term environmental safety studies have also found that many nanomaterials adsorb (form a thin film) on the surface of organisms’ – such as algae and water fleas – epidermis. The materials are also distributed in both gut systems and throughout small creatures’ bodies.
It is vitally important we get to grips with the potential adverse impacts of nanomaterials before widespread environmental dispersion occurs. At present, the long-term effects of nanomaterial exposure on ecosystems is poorly understood. Nor do we know the impact of nanomaterial exposure on the food chain. They could affect feeding rates as well as the behaviour and survival of different species, for example.
httpv://www.youtube.com/watch?v=MkpcUpattE8
We also don’t know enough about how nanomaterials can affect humans when exposed in small doses and over long periods. The most important routes of exposure for humans are the lungs, gut and skin. Nanomaterials are being incorporated into food products and packaging, and they may be inhaled or swallowed by workers during manufacturing, too. Tests have shown that once nanomaterials enter the body they become trapped in the liver, but we don’t know what risk they pose long term.
The current standard non-animal safety tests for human lung, gut and skin exposure are very simplistic. For example, to determine the biological impact of inhaling nanomaterials, scientists grow a single lung cell system in the lab and expose it to nanomaterials suspended in liquid. But there are over 40 different cell types within the human lung. These kinds of tests cannot accurately predict the potential harm associated with nanomaterial exposure. Nor accurately mimic the complexity of the human body or the manner in which we encounter nanomaterials.
The next generation
The world has already experienced the problems that can come with new innovations. Given the world’s experiences with asbestos (which, though having been used for thousands of years, was only discovered as a source of diseases in the 1900s), the controversial development of genetically modified foods, and the highly topical microplastics crisis, it is imperative that advances in nanotechnology do not result in similar health crises.
Our research team is now working to improve nanotechnology tests, through the Horizon 2020-funded project PATROLS. Bringing together leading international nanosafety, ecotoxicology, tissue engineering and computational modelling experts from all over the world, our aim is to build on international best practice and address the current testing limitations.
We are already adopting cutting-edge science to develop advanced tissue models of the lung, gut and liver for nanomaterial safety assessment. We’re working on new safety assessment methods for environmentally relevant test systems and organisms (including algae, water fleas and zebrafish), which have been selected according to their position in the food chain. These next generation, non-animal tests are aimed at reducing the reliance on animal testing, too, while promoting the responsible development of the nanotechnology industry.
In addition, we are working to create a way of predicting human and environmental nanomaterial safety based on computational models. This will allow screening of new nanomaterials using a computer database as an initial safety check before further testing is carried out.
By improving non-animal tests for nanotechnology, we can help protect consumers, workers and the environment from any health or safety risks that they would potentially cause. Nanotechnology has already shown that it can enhance our lives, and with an improved understanding of their safety, we can more confidently enjoy the benefits this new technology offers.
_________________________________________
Shareen Doak – Professor of Genotoxicology and Cancer, Swansea University
Martina G. Vijver – Professor of Ecotoxicology, Leiden University
Martin Clift – Senior Lecturer, Swansea University
Republish our articles for free, online or in print, under Creative Commons license.
Go to Original – theconversation.com
DISCLAIMER: The statements, views and opinions expressed in pieces republished here are solely those of the authors and do not necessarily represent those of TMS. In accordance with title 17 U.S.C. section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. TMS has no affiliation whatsoever with the originator of this article nor is TMS endorsed or sponsored by the originator. “GO TO ORIGINAL” links are provided as a convenience to our readers and allow for verification of authenticity. However, as originating pages are often updated by their originating host sites, the versions posted may not match the versions our readers view when clicking the “GO TO ORIGINAL” links. This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.